Back to search

How to use the evidence: assessment and application of scientific evidence

Data up to Jan 2025

Published2000
Citations336
References70

Total Citations Per Year

Abstract

References (70)

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

1993 • 23,535 citations

Assessing the quality of reports of randomized clinical trials: Is blinding necessary?

1996 • 17,261 citations

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)

1996 • 6,350 citations

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women

1998 • 6,250 citations

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1995 • 5,696 citations

The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male Smokers

1994 • 4,626 citations

Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease

1996 • 3,608 citations

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1998 • 3,578 citations

Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction

1989 • 3,227 citations

Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease

1996 • 2,429 citations

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

1997 • 2,394 citations

Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women

1992 • 2,379 citations

Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection

1997 • 2,097 citations

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

1998 • 1,575 citations

Physical Activity and the Incidence of Coronary Heart Disease

1987 • 1,471 citations

A Comparison of Results of Meta-analyses of Randomized Control Trials and Recommendations of Clinical Experts

1992 • 1,451 citations

A META-ANALYSIS OF PHYSICAL ACTIVITY IN THE PREVENTION OF CORONARY HEART DISEASE

1990 • 1,411 citations

Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists

1995 • 1,323 citations

A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease

1994 • 953 citations

A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult

1998 • 837 citations

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

1996 • 829 citations

Users' Guides to the Medical Literature

1995 • 816 citations

Donepezil Improves Cognition and Global Function in Alzheimer Disease<subtitle>A 15-Week, Double-blind, Placebo-Controlled Study</subtitle>

1998 • 753 citations

"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.

1983 • 615 citations

How to read a paper: Papers that summarise other papers (systematic reviews and meta-analyses)

1997 • 559 citations

European Stroke Prevention Study 2

1995 • 538 citations

Dietary Carotenes, Vitamin C, and Vitamin E as Protective Antioxidants in Human Cancers

1992 • 532 citations

How study design affects outcomes in comparisons of therapy. I: Medical

1989 • 528 citations

Aspirin and Risk of Hemorrhagic Stroke

1998 • 513 citations

Assessing the Quality of Randomized Controlled Trials:Current Issues and Future Directions

1996 • 452 citations

An evidence based approach to individualising treatment

1995 • 369 citations

Large Trials vs Meta-analysis of Smaller Trials

1996 • 337 citations

Are Surrogate Markers Adequate to Assess Cardiovascular Disease Drugs?

1999 • 332 citations

Individual risk assessment for intracranial haemorrhage during thrombolytic therapy

1993 • 302 citations

Can overall results of clinical trials be applied to all patients?

1995 • 298 citations

Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke

1997 • 285 citations

Clinical Decision Making: From Theory to Practice

1996 • 281 citations

Changes in Plasma HIV RNA Levels and CD4+ Lymphocyte Counts Predict Both Response to Antiretroviral Therapy and Therapeutic Failure

1997 • 267 citations

Anatomy of a Decision

1990 • 261 citations

INTRAVENOUS MAGNESIUM IN ACUTE MYOCARDIAL INFARCTION

1986 • 253 citations

How to review the evidence: systematic identification and review of the scientific literature

2000 • 238 citations

Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: The CAPS

1988 • 233 citations

An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials

1998 • 213 citations

A Prognostic Model for Predicting 10-Year Survival in Patients with Primary Melanoma

1996 • 200 citations

Clinical decision making: from theory to practice. Anatomy of a decision

1990 • 182 citations

The relation between treatment benefit and underlying risk in meta-analysis

1996 • 167 citations

Locating and Appraising Systematic Reviews

1997 • 166 citations

Life-Threatening Interaction of Mibefradil and β-Blockers With Dihydropyridine Calcium Channel Blockers

1998 • 156 citations

Methodologic standards and contradictory results in case-control research

1979 • 155 citations

Oral contraceptives and cardiovascular disease: A critique of the epidemiologic studies

1985 • 151 citations

Clinical Trials and Statistical Verdicts: Probable Grounds for Appeal

1983 • 139 citations

Randomised controlled trial of effect of feedback on general practitioners' prescribing in Australia

1999 • 135 citations

THE POPULATION RISK AS AN EXPLANATORY VARIABLE IN RESEARCH SYNTHESIS OF CLINICAL TRIALS

1996 • 128 citations

Comparing benefits and harms: the balance sheet

1990 • 113 citations

Guidelines for reading case-control studies

1987 • 107 citations

Method for evaluating research and guideline evidence

1997 • 103 citations

Clinical Measurement in Drug Evaluation

1991 • 98 citations

Tailored thrombolytic therapy. A perspective.

1993 • 84 citations

Variation in baseline risk as an explanation of heterogeneity in meta-analysis

1997 • 82 citations

Statistical significance and confidence intervals

1986 • 74 citations

An approach to the development of practice guidelines for community health interventions.

1994 • 71 citations

Applying the results of trials and systematic reviews to individual patients.

1998 • 68 citations

An Effect Model for the Assessment of Drug Benefit

1993 • 60 citations

Large trials with simple protocols: Indications and contraindications

1989 • 44 citations

How to compare the costs and benefits: evaluation of the economic evidence

2001 • 38 citations

Interpretation of results from subset analyses within overviews of randomized clinical trials

1987 • 37 citations

Development of the AHCPR-Sponsored Heart Failure Guideline: Methodologic and Procedural Issues

1994 • 31 citations

Why is antihypertensive drug therapy needed in elderly patients with systolodiastolic hypertension?

1994 • 19 citations

Quality of published reports of the prognosis of community-acquired pneumonia

1994 • 16 citations

The short life and rapid death of a novel antihypertensive and antianginal agent

1998 • 6 citations

Cited By (0)

Loading...